Sanctuary Advisors LLC Invests $66,000 in ASP Isotopes Inc. (NASDAQ:ASPI)

Sanctuary Advisors LLC purchased a new stake in ASP Isotopes Inc. (NASDAQ:ASPI) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 23,642 shares of the company’s stock, valued at approximately $66,000.

A number of other large investors have also added to or reduced their stakes in the stock. The Manufacturers Life Insurance Company acquired a new stake in ASP Isotopes in the third quarter valued at about $52,000. KKM Financial LLC grew its position in shares of ASP Isotopes by 66.2% during the 3rd quarter. KKM Financial LLC now owns 22,600 shares of the company’s stock worth $63,000 after buying an additional 9,000 shares during the period. MetLife Investment Management LLC acquired a new position in ASP Isotopes during the 3rd quarter worth approximately $88,000. Verition Fund Management LLC bought a new position in shares of ASP Isotopes in the third quarter valued at $101,000. Finally, Rhumbline Advisers bought a new position in shares of ASP Isotopes in the second quarter valued at approximately $116,000. Institutional investors and hedge funds own 16.80% of the company’s stock.

ASP Isotopes Price Performance

ASPI opened at $4.58 on Tuesday. The stock’s 50 day simple moving average is $5.94 and its 200 day simple moving average is $3.93. ASP Isotopes Inc. has a 1 year low of $1.65 and a 1 year high of $9.33. The firm has a market cap of $326.97 million, a price-to-earnings ratio of -7.51 and a beta of 3.27. The company has a debt-to-equity ratio of 0.80, a current ratio of 7.55 and a quick ratio of 7.54.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ASPI. Canaccord Genuity Group assumed coverage on ASP Isotopes in a research report on Friday, October 4th. They issued a “buy” rating and a $4.50 price objective on the stock. Canaccord Genuity Group reiterated a “buy” rating and set a $4.50 price target on shares of ASP Isotopes in a research report on Friday, October 18th.

ASP Isotopes Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.